Prediction of Childhood Epilepsy Outcome in Bangladesh
1 other identifier
interventional
92
2 countries
2
Brief Summary
Randomised controlled trial of the use of phenobarbitone and carbamazepine in childhood epilepsy in Bangladesh with particular reference to behavioural side effects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 27, 2006
CompletedFirst Posted
Study publicly available on registry
September 28, 2006
CompletedDecember 25, 2006
December 1, 2006
September 27, 2006
December 22, 2006
Conditions
Keywords
Interventions
Eligibility Criteria
You may qualify if:
- Active epilepsy
- Aged 2-15 years
You may not qualify if:
- Excluded absence
- Myoclonic and malignant epilepsy syndromes
- Major motor and cognitive impairments
- Those currently receiving antiepilepsy drugs.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Children's Hospital Dhaka (Shishu) Bangladesh.
Sher-e-Bangla Nagar, Dhaka 1207, Bangladesh
Institute of Child Health
London, WC1N 1EH, United Kingdom
Related Publications (1)
Banu SH, Jahan M, Koli UK, Ferdousi S, Khan NZ, Neville B. Side effects of phenobarbital and carbamazepine in childhood epilepsy: randomised controlled trial. BMJ. 2007 Jun 9;334(7605):1207. doi: 10.1136/bmj.39022.436389.BE. Epub 2006 Dec 4.
PMID: 17145735DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Brian Neville, Professor
Institute of Child Health
- PRINCIPAL INVESTIGATOR
Selina Banu, Dr
Children's Hospital Dhaka (Shishu) Bangladesh.